Peripheral Blood Mononuclear Cells Market to be Valued USD 268.58 Million by 2025

Growing utilization of peripheral blood mononuclear cells in clinical and research applications to drive peripheral blood mononuclear cells market

According to TechSci Research report, “Global Peripheral Blood Mononuclear Cells Market By Product, By Application, By Technique, By Source, By Region, Competition, Forecast & Opportunities, 2025”, the global peripheral blood mononuclear cells market was valued at 172.29 Million in 2019 and is projected to grow at a CAGR of 8.46% during 2020 – 2025. PBMC are also called human mononuclear cells from peripheral blood (HMNC-PB) and are made up of lymphocytes & monocytes, and in humans, major composition of PBMC consists of lymphocytes, followed by monocytes and dendritic cells. PBMC is crucial to carry out the studies related to biology and pathology and are also quite useful in clinical applications and research. Additionally, PMBCs help to find characteristics which are important for research areas such as immunology, transplant immunology, vaccine development, hematological malignancies, and others. However, developing nations tend to lack research practices due to less research institutes, which can eventually lead to less usage of PBMCs, thereby restraining the market growth.

Browse 156 Figures spread through 168 Pages and an in-depth TOC on “ Global Peripheral Blood Mononuclear Cells Market”

https://www.techsciresearch.com/report/peripheral-blood-mononuclear-cells-market/4561.html

The global peripheral blood mononuclear cells market is segmented into product, application, technique, source, and region. Based on product, the market is segmented into cryopreserved or frozen PBMC, cultured or fresh PBMC and peripheral blood mononuclear cell isolation & viability kits. Cryopreserved PBMC segment is expected to dominate the market during the forecast period as frozen PBMC find wide application in clinical trials. Moreover, PBMCs can be used for long durations of time if they are stored in a proper way and at lower temperatures. They can even substitute fresh PBMCs in few applications and thus, making it feasible for the scientists and researchers to carry out various tests in one laboratory avoiding inter-laboratory issues. Based on regional analysis, as of 2019, North America held the largest market share in the global peripheral blood mononuclear cells market and the region is anticipated to hold its position during the forecast period. This is majorly due to the presence of pre-existing PBMC based research organizations and lab service providers in the region.

Some of the major players in the global peripheral blood mononuclear cells market include Thermo Fisher Scientific Inc., Merck & Co., Inc., Corning Incorporate, Bio-Rad Laboratories, Inc., Cellero, LLC, Life Technologies (India) Pvt. Ltd., Cell Applications, Inc., DAPCEL, Inc., Creative Bioarray, iXCells Biotechnologies USA, LLC, Miltenyi Biotec B.V. & CO. KG, STEMCELL Technologies Inc., Precision Medicine Group, LLC., StemExpress, LLC, HemaCare Corporation, BioVision, Inc., BioLegend, Inc., BioIVT LLC, Biopredic International, Zen-Bio Inc., among others. In order to increase their market share, a rising number of companies are adopting various strategies including collaborations to attract more customers. For instance, Miltenyi Biotec, an European PBMC based company, launched a new MACSprep PBMC Isolation Kit in June 14, 2017. The kit is used for processing and diagnosis of small blood samples as it prepares extremely pure PBMCs via the blood in a very short span of time without using the procedure of centrifugation.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4561

Customers can also request for 10% free customization on this report.

“Global peripheral blood mononuclear cells market is anticipated to witness a formidable growth over the course of next five years. Increase in number of diseases and rise in number of PBMC based research organizations are some of the major factors driving the market across the globe. Additionally, increasing incidents of autoimmune and metabolic diseases are positively influencing the growth of the market as PBMC is used in studies related to such diseases.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Peripheral Blood Mononuclear Cells Market By Product, By Application, By Technique, By Source, By Region, Competition, Forecast & Opportunities, 2025” has evaluated the future growth potential of global peripheral blood mononuclear cells market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in the global peripheral blood mononuclear cells market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]